Siemens Healthineers and Novo join forces to advance care for people living with MASLD and MASHSeptember 22, 2026
Galimedix establishes Scientific Advisory Board for Alzheimer’s disease to guide development of novel oral drug candidate, GAL-101September 22, 2026
General Siemens Healthineers and Novo join forces to advance care for people living with MASLD and MASHBy Healthcare Propulsion StaffSeptember 22, 20260 Siemens Healthineers and Novo have announced a collaboration focused on advancing care for people living with metabolic dysfunction-associated steatotic liver…
